1
|
Blanco Terés L, Cerdán Santacruz C, Correa Bonito A, Delgado Búrdalo L, Rodríguez Sánchez A, Bermejo Marcos E, García Septiem J, Martín Pérez E. Early diverting stoma closure is feasible and safe: results from a before-and-after study on the implementation of an early closure protocol at a tertiary referral center. Tech Coloproctol 2024; 28:32. [PMID: 38349559 DOI: 10.1007/s10151-023-02905-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Accepted: 12/18/2023] [Indexed: 02/15/2024]
Abstract
BACKGROUND Evidence on early closure (EC) of defunctioning stoma (DS) after colorectal surgery shows a favorable effect when patients are carefully selected. Therefore, a clinical pathway adapted to the implementation of an EC strategy was developed in our center. The aim of this study was to carry out a comparative analysis of time until DS closure and DS-related morbidity before and after the implementation of an EC protocol (ECP). METHODS This study is a before-and-after comparative analysis. Patients were divided into two cohorts according to the observational period: patients from the period before the ECP implementation (January 2015-December 2019) [Period 1] and those from the period after that (January 2020-December 2022) [Period 2]. All consecutive patients subjected to elective DS closure within both periods were eligible. Early closure was defined as the reversal within 30 days from DS creation. Patients excluded from EC or those not closed within 30 days since primary surgery were analyzed as late closure (LC). Baseline characteristics and DS-related morbidity were recorded. RESULTS A total of 145 patients were analyzed. Median time with DS was shorter in patients after ECP implementation [42 (21-193) days versus 233 (137-382) days, p < 0.001]. This reduction in time to closure did not impact the DS closure morbidity and resulted in less DS morbidity (68.8% versus 49.2%, p = 0.017) and fewer stoma nurse visits (p = 0.029). CONCLUSIONS The ECP was able to significantly reduce intervals to restoration of bowel continuity in patients with DS, which in turn resulted in a direct impact on the reduction of DS morbidity without negatively affecting DS closure morbidity.
Collapse
Affiliation(s)
- L Blanco Terés
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
| | - C Cerdán Santacruz
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| | - A Correa Bonito
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| | - L Delgado Búrdalo
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| | - A Rodríguez Sánchez
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| | - E Bermejo Marcos
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| | - J García Septiem
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| | - E Martín Pérez
- General Surgery Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain
| |
Collapse
|
2
|
Rodriguez-Arietaleanizbeaskoa M, Mojas Ereño E, Arietaleanizbeaskoa MS, Grandes G, Rodríguez Sánchez A, Urquijo V, Hernando Alday I, Dublang M, Angulo-Garay G, Cacicedo J. Protocol for the SEHNeCa randomised clinical trial assesing Supervised Exercise for Head and Neck Cancer patients. BMC Cancer 2023; 23:271. [PMID: 36964485 PMCID: PMC10037879 DOI: 10.1186/s12885-023-10718-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Accepted: 03/08/2023] [Indexed: 03/26/2023] Open
Abstract
OBJECTIVES To evaluate the effectiveness of an innovative supervised exercise programme to mitigate the loss of lean body mass, functional capacity and quality of life in people with head and neck cancer, as well as to identify the optimal moment to apply it, before or after radiotherapy treatment, compared with the prescription of a physical activity plan carried out autonomously. METHODS Patients with squamous cell carcinoma of the head and neck (n = 144), treated with radiotherapy, will be randomly assigned to one of 3 comparison groups: pre-radiotherapy supervised exercise, post-radiotherapy supervised exercise and autonomous exercise, stratifying by human papillomavirus infection and previous surgery. The exercise programme will be carried out in 36 sessions over 12 weeks, combining moderate and high intensity strength and aerobic exercises. The main outcome variable is the change in lean body mass at 6 months measured by bioimpedance, while secondary variables are functional capacity, symptoms, quality of life and adverse effects. Longitudinal generalised mixed models will be used for the analyses of the repeated measurements at 3, 6, and 12 months after baseline. CONCLUSIONS The pilot study supports the feasibility and safety of the project. However, as the programme progressed, attendance at the sessions decreased. Strategies will be necessary for increasing attendance, as well as involving the patient in their recovery and other incentives. Follow-up after treatment to assess acute/late toxicity will enable us to know the response to both the exercise programme and its adherence. TRIAL REGISTRATION NCT04658706 Date and version identifier: March 1, 2023. Version 1.1.
Collapse
Affiliation(s)
- M Rodriguez-Arietaleanizbeaskoa
- Comprehensive Care Group for Patients With Chronic Diseases, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo, Bizkaia, Spain.
| | - E Mojas Ereño
- AFD Salud. Department of Physical Activity and Sport Sciences, Faculty of Education and Sport, University of Deusto, Bizkaia, 48007, Spain
| | - M S Arietaleanizbeaskoa
- Comprehensive Care Group for Patients With Chronic Diseases, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo, Bizkaia, Spain
| | - G Grandes
- Primary Care Research Unit - Bizkaia, Basque Health Service (Osakidetza), General Directorate, Vitoria-Gasteiz, Spain
| | - A Rodríguez Sánchez
- Basurto Radiation Oncology Department, Avenida Montevideo 18, 48013, Bilbao, Bizkaia, Spain
| | - V Urquijo
- Cruces Endocrinology Department, Plaza de Cruces S/N, 48903, Barakaldo, Bizkaia, Spain
| | - I Hernando Alday
- Basurto Endocrinology Department, Avenida Montevideo 18, 48013, Bilbao, Bizkaia, Spain
| | - M Dublang
- Galdakao Endocrinology Department, Barrio Labeaga, 48960, Galdakao, Bizkaia, Spain
| | - G Angulo-Garay
- AFD Salud. Department of Physical Activity and Sport Sciences, Faculty of Education and Sport, University of Deusto, Bizkaia, 48007, Spain
| | - J Cacicedo
- Department of Radiation Oncology, Group for Radiology and Physical Medicine in Oncology, Cruces University Hospital/Biocruces Bizkaia Health Research Institute, Barakaldo, 48903, Spain
| | | |
Collapse
|
3
|
García Morales L, Rodríguez Arnao MD, Rodríguez Sánchez A, Dulín Íñiguez E, Álvarez González MA. Sustained attention in school-age children with congenital hypothyroidism: Influence of episodes of overtreatment in the first three years of life. Neurologia 2020; 35:226-232. [PMID: 29162287 DOI: 10.1016/j.nrl.201708.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 07/24/2017] [Accepted: 08/15/2017] [Indexed: 05/24/2023] Open
Abstract
INTRODUCTION Children with congenital hypothyroidism (CH) are at risk of developing mild cognitive impairment despite normal overall intellectual performance. These deficits may be caused by disease-related and treatment-related factors. This study explores the impact of abnormal thyroid function during the first 3 years of life on attention performance at school age. METHODS We included 49 children diagnosed with CH and receiving treatment for the condition: 14 boys (mean age 9.5±2.8 years) and 35 girls (9.6±2.6 years). The number of episodes of normal, under-, and overtreatment were estimated based on TSH levels during their first 3 years of life (at 12, 18, 24, 30, and 36 months). Children were assessed using a computerised version of a Sustained attention test. General linear models were calculated with the attention index as the dependent variable and sex, aetiology, and number of episodes of normal, under-, and overtreatment as independent variables. RESULTS Higher numbers of episodes of overtreatment (low TSH level) were associated with poorer attention performance at school age (P=.005, r=-0.45). CONCLUSIONS Children with CH should be monitored closely during the first 3 years of life in order to prevent not only hypothyroidism but also any adverse effects of overtreatment that may affect attentional function at school age.
Collapse
Affiliation(s)
| | - M D Rodríguez Arnao
- Unidad Endocrina Pediátrica, Laboratorio de Desórdenes Metabólicos del Hospital Universitario Gregorio Marañón, Madrid, España
| | - A Rodríguez Sánchez
- Unidad Endocrina Pediátrica, Laboratorio de Desórdenes Metabólicos del Hospital Universitario Gregorio Marañón, Madrid, España
| | - E Dulín Íñiguez
- Laboratorio de Desórdenes Metabólicos del Hospital Universitario Gregorio Marañón, Madrid, España
| | - M A Álvarez González
- Instituto Superior de Diseño, Universidad de La Habana, Instituto de Neurología y Neurocirugía de La Habana, La Habana, Cuba
| |
Collapse
|
4
|
Mora-Guzmán I, Di Martino M, Muñoz de Nova J, Viamontes Ugalde F, Rodríguez Sánchez A. Primary signet ring cell carcinoma of the colon: A rare condition with a poor prognosis. A report on two cases. Revista de Gastroenterología de México (English Edition) 2018. [DOI: 10.1016/j.rgmxen.2017.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
5
|
García Morales L, Rodríguez Arnao MD, Rodríguez Sánchez A, Dulín Íñiguez E, Álvarez González MA. Sustained attention in school-age children with congenital hypothyroidism: Influence of episodes of overtreatment in the first three years of life. Neurologia 2017; 35:226-232. [PMID: 29162287 DOI: 10.1016/j.nrl.2017.08.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 07/24/2017] [Accepted: 08/15/2017] [Indexed: 11/24/2022] Open
Abstract
INTRODUCTION Children with congenital hypothyroidism (CH) are at risk of developing mild cognitive impairment despite normal overall intellectual performance. These deficits may be caused by disease-related and treatment-related factors. This study explores the impact of abnormal thyroid function during the first 3 years of life on attention performance at school age. METHODS We included 49 children diagnosed with CH and receiving treatment for the condition: 14 boys (mean age 9.5±2.8 years) and 35 girls (9.6±2.6 years). The number of episodes of normal, under-, and overtreatment were estimated based on TSH levels during their first 3 years of life (at 12, 18, 24, 30, and 36 months). Children were assessed using a computerised version of a Sustained attention test. General linear models were calculated with the attention index as the dependent variable and sex, aetiology, and number of episodes of normal, under-, and overtreatment as independent variables. RESULTS Higher numbers of episodes of overtreatment (low TSH level) were associated with poorer attention performance at school age (P=.005, r=-0.45). CONCLUSIONS Children with CH should be monitored closely during the first 3 years of life in order to prevent not only hypothyroidism but also any adverse effects of overtreatment that may affect attentional function at school age.
Collapse
Affiliation(s)
| | - M D Rodríguez Arnao
- Unidad Endocrina Pediátrica, Laboratorio de Desórdenes Metabólicos del Hospital Universitario Gregorio Marañón, Madrid, España
| | - A Rodríguez Sánchez
- Unidad Endocrina Pediátrica, Laboratorio de Desórdenes Metabólicos del Hospital Universitario Gregorio Marañón, Madrid, España
| | - E Dulín Íñiguez
- Laboratorio de Desórdenes Metabólicos del Hospital Universitario Gregorio Marañón, Madrid, España
| | - M A Álvarez González
- Instituto Superior de Diseño, Universidad de La Habana, Instituto de Neurología y Neurocirugía de La Habana, La Habana, Cuba
| |
Collapse
|
6
|
Mora-Guzmán I, Di Martino M, Muñoz de Nova JL, Viamontes Ugalde FE, Rodríguez Sánchez A. Primary signet ring cell carcinoma of the colon: A rare condition with a poor prognosis. A report on two cases. Rev Gastroenterol Mex (Engl Ed) 2017; 83:358-360. [PMID: 28684029 DOI: 10.1016/j.rgmx.2017.03.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/16/2016] [Revised: 02/01/2017] [Accepted: 03/14/2017] [Indexed: 01/27/2023]
Affiliation(s)
- I Mora-Guzmán
- Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España.
| | - M Di Martino
- Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España
| | - J L Muñoz de Nova
- Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España
| | - F E Viamontes Ugalde
- Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España
| | - A Rodríguez Sánchez
- Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España
| |
Collapse
|
7
|
Abstract
Tailgut cysts are rare benign retrorectal cysts arising from persistent remnants of an embryonic hindgut. Malignant transformation inside this lesion is very uncommon and occurrence of neuroendocrine tumours in this context is extremely rare. We report the case of a 56-year-old woman who underwent surgical excision of a presacral tailgut cyst, which was found incidentally to include a neuroendocrine tumour.
Collapse
Affiliation(s)
- I Mora-Guzmán
- Hospital Universitario de la Princesa , Madrid , Spain
| | | | | | | |
Collapse
|
8
|
Grande E, Fernández Pérez M, Font A, Vazquez S, Mellado B, Fernandez Calvo O, Méndez Vidal M, Climent M, González del Alba A, Gallardo E, Rodríguez Sánchez A, Santander C, Sáez M, Duran I, Puente J, Alonso Gordoa T, Tudela J, Martínez A, Castellano D, González Billalabeitia E. Early responses to enzalutamide in AR-V7 positive first line metastatic castration-resistant prostate cancer (mCRPC). A prospective SOGUG clinical trial: The PREMIERE study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw372.10] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Pérez-Valderrama B, Arranz Arija JA, Rodríguez Sánchez A, Pinto Marín A, Borrega García P, Castellano Gaunas DE, Rubio Romero G, Maximiano Alonso C, Villa Guzmán JC, Puertas Álvarez JL, Chirivella González I, Méndez Vidal MJ, Juan Fita MJ, León-Mateos L, Lázaro Quintela M, García Domínguez R, Jurado García JM, Vélez de Mendizábal E, Lambea Sorrosal JJ, García Carbonero I, González del Alba A, Suárez Rodríguez C, Jiménez Gallego P, Meana García JA, García Marrero RD, Gajate Borau P, Santander Lobera C, Molins Palau C, López Brea M, Fernández Parra EM, Reig Torras O, Basterretxea Badiola L, Vázquez Estévez S, González Larriba JL. Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study. Ann Oncol 2015; 27:706-11. [PMID: 26658889 DOI: 10.1093/annonc/mdv601] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2015] [Accepted: 11/27/2015] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Patients with metastatic renal carcinoma (mRCC) treated with first-line pazopanib were not included in the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model. SPAZO (NCT02282579) was a nation-wide retrospective observational study designed to assess the effectiveness and validate the IMDC prognostic model in patients treated with first-line pazopanib in clinical practice. PATIENTS AND METHODS Data of 278 patients, treated with first-line pazopanib for mRCC in 34 centres in Spain, were locally recorded and externally validated. Mean age was 66 years, there were 68.3% male, 93.5% clear-cell type, 74.8% nephrectomized, and 81.3% had ECOG 0-1. Metastatic sites were: lung 70.9%, lymph node 43.9%, bone 26.3%, soft tissue/skin 20.1%, liver 15.1%, CNS 7.2%, adrenal gland 6.5%, pleura/peritoneum 5.8%, pancreas 5%, and kidney 2.2%. After median follow-up of 23 months, 76.4% had discontinued pazopanib (57.2% due to progression), 47.9% had received second-line targeted therapy, and 48.9% had died. RESULTS According to IMDC prognostic model, 19.4% had favourable risk (FR), 57.2% intermediate risk (IR), and 23.4% poor risk (PR). No unexpected toxicities were recorded. Response rate was 30.3% (FR: 44%, IR: 30% PR: 17.3%). Median progression-free survival (whole population) was 11 months (32 in FR, 11 in IR, 4 in PR). Median and 2-year overall survival (whole population) were 22 months and 48.1%, respectively (FR: not reached and 81.6%, IR: 22 and 48.7%, PR: 7 and 18.8%). These estimations and their 95% confidence intervals are fully consistent with the outcomes predicted by the IMDC prognostic model. CONCLUSION Our results validate the IMDC model for first-line pazopanib in mRCC and confirm the effectiveness and safety of this treatment.
Collapse
Affiliation(s)
- B Pérez-Valderrama
- Department of Medical Oncology, Virgen del Rocío University Hospitals, Sevilla
| | - J A Arranz Arija
- Department of Medical Oncology, Gregorio Marañón General University Hospital, Madrid
| | | | - A Pinto Marín
- Department of Medical Oncology, La Paz University Hospital, Madrid
| | - P Borrega García
- Department of Medical Oncology, San Pedro de Alcántara Hospital, Cáceres
| | | | - G Rubio Romero
- Department of Medical Oncology, Fundación Jiménez Díaz University Hospital, Madrid
| | - C Maximiano Alonso
- Department of Medical Oncology, Puerta de Hierro University Hospital, Majadahonda (Madrid)
| | - J C Villa Guzmán
- Department of Medical Oncology, General University Hospital of Ciudad Real, Ciudad Real
| | | | | | - M J Méndez Vidal
- Department of Medical Oncology, Reina Sofía University Hospital, Córdoba
| | - M J Juan Fita
- Department of Medical Oncology, Valencian Institute of Oncology, Valencia
| | - L León-Mateos
- Department of Medical Oncology, Santiago University Hospital Complex, Santiago de Compostela
| | - M Lázaro Quintela
- Department of Medical Oncology, University Hospital Complex of Vigo, Vigo
| | - R García Domínguez
- Department of Medical Oncology, Clinic University Hospital of Salamanca, Salamanca
| | - J M Jurado García
- Department of Medical Oncology, San Cecilio University Hospital, Granada
| | | | | | | | - A González del Alba
- Department of Medical Oncology, Son Espases University Hospital, Palma de Mallorca
| | - C Suárez Rodríguez
- Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona
| | - P Jiménez Gallego
- Department of Medical Oncology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas de Gran Canaria
| | - J A Meana García
- Department of Medical Oncology, University Hospital of Alicante, Alicante
| | - R D García Marrero
- Department of Medical Oncology, University Hospital of Canarias, San Cristóbal de La Laguna (Santa Cruz de Tenerife)
| | - P Gajate Borau
- Department of Medical Oncology, Quirón University Hospital, Madrid
| | - C Santander Lobera
- Department of Medical Oncology, Miguel Servet University Hospital, Zaragoza
| | - C Molins Palau
- Department of Medical Oncology, Doctor Peset University Hospital, Valencia
| | - M López Brea
- Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander
| | - E M Fernández Parra
- Department of Medical Oncology, Nuestra Señora de Valme University Hospital, Sevilla
| | - O Reig Torras
- Department of Medical Oncology, Clinic University Hospital of Barcelona, Barcelona
| | | | - S Vázquez Estévez
- Department of Medical Oncology, Lucus Augusti University Hospital, Lugo
| | | |
Collapse
|
10
|
Arija JA, Pérez-Valderrama B, González-Larriba J, Rodríguez Sánchez A, Chirivella I, Pinto A, Marrero RG, Rubio G, García JJ, Borrega P, Quintela ML, Castellano D, Rodríguez CS, García JM, Lambea-Sorrosal J, Gajate P, Fita MJ, Puertas J, Domínguez RG, Guzmán JV. 2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG). Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31455-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
11
|
Perez-Valderrama B, Arija JA, Vidal MM, Carbonero IG, Rodríguez CS, Gallego PJ, López-Brea M, Marrero RG, García JM, Gajate P, Santander C, Palau CM, Parra EF, Torras OR, Basterrechea L, Estévez SV, Borrega P, Sánchez AR, Pinto A, Castellano D. 2602 Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC). The SPAZO study (SOGUG). Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31420-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
12
|
Pérez Moreno J, Muiño Vidal M, Fidalgo Baamil O, Sola Vendrell E, Menárguez Palanca J, Rodríguez Arnao M, Rodríguez Sánchez A. Timo intratiroideo ectópico como causa de nódulo tiroideo solitario. An Pediatr (Barc) 2013; 78:64-5. [DOI: 10.1016/j.anpedi.2012.05.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2012] [Revised: 05/28/2012] [Accepted: 05/29/2012] [Indexed: 11/26/2022] Open
|
13
|
Muíño Vidal M, Pérez Moreno J, Fidalgo Baamil O, Rodríguez Arnao M, Rodríguez Sánchez A. Pubertad precoz central: secuela poco frecuente tras traumatismo craneoencefálico severo. An Pediatr (Barc) 2012; 77:288-9. [DOI: 10.1016/j.anpedi.2012.03.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2011] [Revised: 02/23/2012] [Accepted: 03/27/2012] [Indexed: 11/28/2022] Open
|
14
|
Rodríguez Ogando A, Roldán Martín MB, Rodríguez Arnao MD, Rodríguez Sánchez A. [Congenital panhypopituitarism as part of the solitary median incisor syndrome]. An Pediatr (Barc) 2011; 74:199-201. [PMID: 21342799 DOI: 10.1016/j.anpedi.2010.09.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2010] [Revised: 09/20/2010] [Accepted: 09/21/2010] [Indexed: 11/28/2022] Open
|
15
|
Alvarez M, Iglesias Fernández C, Rodríguez Sánchez A, Dulín Lñiguez E, Rodríguez Arnao MD. Episodes of overtreatment during the first six months in children with congenital hypothyroidism and their relationships with sustained attention and inhibitory control at school age. Horm Res Paediatr 2010; 74:114-20. [PMID: 20395659 DOI: 10.1159/000313370] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2009] [Accepted: 11/12/2009] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND/AIMS Contradictory results regarding the optimal initial dose of levothyroxine in children with congenital hypothyroidism (CH) hamper the clinical management of these children during their early infancy. We explore the relationships between the initial dose of levothyroxine and endocrine control during the first 6 months and cognition at school age. SUBJECTS AND METHODS Fifty children with CH, 14 boys (10+/-3.1 years) and 36 girls (9.7+/-2.6 years), at the Pediatric Endocrine Unit of the Hospital Gregorio Marañón in Madrid were studied. Neurocognitive evaluation was carried out exploring alertness and inhibitory control. The number of episodes of overtreatment during the first 6 months, the initial dose of levothyroxine, etiology and sex were the predictor variables. RESULTS Inhibitory control was significantly lower in children with CH than in controls. An interaction with gender and etiology was obtained. Alertness had an inverse relationship with the number of episodes of overtreatment with no interaction with gender or etiology. CONCLUSION Episodes of overtreatment and not the initial dose of levothyroxine are a risk factor for deficit in alertness whereas subtle inhibitory control deficit seems to be a permanent problem with the current therapeutic approach.
Collapse
Affiliation(s)
- M Alvarez
- Faculty of Psychology, University of Havana, Cuba.
| | | | | | | | | |
Collapse
|
16
|
Pita Gutiérrez F, Crespo Marcos D, Iglesias Fernández C, Rodríguez Sánchez A, Rodríguez Arnao M. Enfermedad tiroidea autoinmunitaria: posibilidad de asociación a gastritis autoinmunitaria. An Pediatr (Barc) 2009; 71:240-3. [DOI: 10.1016/j.anpedi.2009.05.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2009] [Revised: 05/26/2009] [Accepted: 05/27/2009] [Indexed: 10/20/2022] Open
|
17
|
Crespo Marcos D, López-Menchero Oliva J, Carreño Beltrán A, Rodríguez Fernández R, Rodríguez Sánchez A. Déficit de acil-coenzima A deshidrogenasa de ácidos grasos de cadena media. An Pediatr (Barc) 2008; 68:302-4. [DOI: 10.1157/13116715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
18
|
Abstract
We describe a 25-year-old Caucasian man with a 13-year history of inflammatory Crohn's disease (CD) who was suffering recurrent severe oral and esophageal ulcerations for the past 3 years. His CD had been treated with infliximab infusions among other medications. The loss of efficacy was confirmed by antibodies to infliximab (ATI) and serum infliximab tests that showed high levels of ATIs and undetectable levels of infliximab respectively. These findings were consistent with significant immunogenic response to infliximab leading to loss of effect. Infliximab infusions and prednisone were discontinued and treatment of the CD was instituted with adalimumab, a human anti-tumor necrosis factor (TNF)-alpha biologic agent, to control the inflammatory small intestinal disease and dapsone for the oral and esophageal CD ulcerations. The patient's oral and esophageal lesions as well as the enteric CD are under control after 5 months of therapy.
Collapse
Affiliation(s)
- A R Sánchez
- Division of Periodontics, Department of Dental Specialties, Mayo Clinic, Mayo Building, Rochester, MN 55905, USA.
| | | | | |
Collapse
|
19
|
Martín García G, Torrego García JC, Rodríguez Sánchez A, García Domínguez R, Santos de Vega G. [Fever and abdominal pain in a neutropenic patient]. Rev Clin Esp 2002; 202:563-4. [PMID: 12361558 DOI: 10.1016/s0014-2565(02)71144-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Affiliation(s)
- G Martín García
- Servicios de Oncología Médica. Hospital Universitario de Salamanca. Spain
| | | | | | | | | |
Collapse
|
20
|
Rodríguez Sánchez A. [Not Available]. Rev Estud Extremenos 2001; 35:123-64. [PMID: 11632883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
21
|
Vázquez Nava F, Rodríguez Sánchez A, Beltrán Guzmán FJ. [Clinical analysis of the serum levels of IgE in pediatric asthmatic patients]. Rev Alerg Mex 1998; 45:3-6. [PMID: 9718971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
MATERIAL AND METHODS Serum IgE levels and the relationship with some variables in 78 asthmatic children patients, (1 to 5), is reported. RESULTS SHOWED 66% had more than one year of the evolution with the illness, 64% presented more than two asthma episodes per month arid 82% had required hospital care for their stability Laboratory results: 52 patients had higher concentration in IgE serum levels than normal limit (ranges: 8 to 12,000, median 687.27 Ul ml). From these patients, 92% had required hospital care; 96% they had more than 2 years of illness evolution and 72.96% they had a higher concentration of eosinophils. CONCLUSION In this study, the results have allowed us to know characteristics of the patients with high serum IgE levels in our region. Also, the obtained data will allow us to base the design of further research.
Collapse
Affiliation(s)
- F Vázquez Nava
- Departamento de alergia, Hospital General Regional núm, Tams
| | | | | |
Collapse
|
22
|
Puente López G, López-Ríos Velasco J, Pérez Cidoncha P, Pisón Aragón F, Rodríguez Sánchez A. [Cervical cutaneous leishmaniasis]. Acta Otorrinolaringol Esp 1998; 49:250-2. [PMID: 9644870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
A case of cutaneous leishmaniasis that presented as a large cervical ulceration is reported. The etiopathogenesis, clinical manifestations, diagnosis, and treatment are reviewed. The visceral and mucocutaneous forms of the disease were excluded from this study.
Collapse
Affiliation(s)
- G Puente López
- Servicio de ORL, Hospital Don Benito-Villanueva, Badajoz
| | | | | | | | | |
Collapse
|
23
|
Martínez JI, Sánchez AR, Bohórquez JC, Gómez R, Ceijas F, Bohórquez C. Unilateral lower limb hypertrophic osteoarthropathy due to aortic graft infection and aortoenteric fistula. Eur J Vasc Endovasc Surg 1996; 12:497-500. [PMID: 8980444 DOI: 10.1016/s1078-5884(96)80021-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- J I Martínez
- Vascular Surgery Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain
| | | | | | | | | | | |
Collapse
|
24
|
Ramos Pérez PL, Sánchez Segura A, Rodríguez Sánchez A, Alejo M. [Pleomorphic adenoma of the nasal cavity. Presentation of a case]. Acta Otorrinolaringol Esp 1990; 41:111-3. [PMID: 2390294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
We display a case of a female patient with a pleomorphic adenoma localized in the nasal fossa, with 10 years of evolution and that has been extirpated by an external way. We review the bibliography, we emphasize the rareness of the locality and make considerations about clinic, prognostication and treatment.
Collapse
Affiliation(s)
- P L Ramos Pérez
- Sección de ORL, Hospital del Insalud de Don Benito, Villanueva, Badajoz
| | | | | | | |
Collapse
|
25
|
Sánchez Segura A, Ramos Pérez PL, Rodríguez Sánchez A, Aguirre Sánchez JJ, Gutiérrez Díez JA, Alvarez Domínguez J. [Laryngeal paralysis and olivopontocerebellar atrophy. Apropos of a case]. Acta Otorrinolaringol Esp 1990; 41:96-8. [PMID: 2390302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
We display the study performed to a female patient affected of laryngeal paralysis to become, based in clinical and radiologic criteria, to diagnose her cerebellar atrophy. We justify our work because of how infrequently this illness heredodegenerative of the central nervous system begins with cranial pairs paralysis. We emphasize the importance that the new methods of explorations specially TAC and IRM, have to guess the possible etiologies of central originated paralysis.
Collapse
Affiliation(s)
- A Sánchez Segura
- Hospital Juan Sánchez Cortés, Insalud de Don Benito-Villanueva, Serena, Badajoz
| | | | | | | | | | | |
Collapse
|